FIELD: medicine; neurology.
SUBSTANCE: invention refers to treating multiple sclerosis. That is ensured by administering somatotropin in amount of 0.05 to 0.5 IU/kg of body weight, or insulin-like growth factor 1 (IGF-1) in amount of 50 to 500 mcg/kg of body weight, or their physiological inducers.
EFFECT: this provides effective reduction of the disease symptoms with no side effects.
4 cl, 2 tbl, 2 ex
Title |
Year |
Author |
Number |
HYBRID PROTEIN IGF-1-LONG FOR TREATING STROKE, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
2018 |
- Dukhovlinov Ilya Vladimirovich
|
RU2711111C1 |
NEW METHODS FOR TREATING MULTIPLE SCLEROSIS |
2018 |
|
RU2765820C2 |
METHOD FOR TREATING MULTIPLE SCLEROSIS USING LSD1 INHIBITOR |
2017 |
- Maes, Tamara
- Mascaro Crusat, Cristina
- Rotllant Pozo, David
|
RU2768120C2 |
TREATMENT OF DEMYELINATING DISEASES |
2019 |
- Kivell, Bronvin Mari
- La Flamme, Anna Kamilla
- Prisintsano, Tomas Edvard
|
RU2805061C2 |
COMPOSITION AND METHOD OF AUTOIMMUNE DISEASES TREATMENT |
2012 |
- Fatkhi Reza
- Maklin Patrik Laflin
- Lejton Garri Dzhefferson
|
RU2621129C2 |
APPLICATION OF 5'-METHYLTHIOADENOSINE (MTA) FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES AND/OR GRAFT REJECTION |
2005 |
- Vil'Oslada Dias Pablo
- Avila Saragosa Matias
- Moreno Bruna Beatris
- Korrales Isk'Erdo Fernando
- Berasajn Lasarte Karmen
- Ruis Garsia-Trevikhano Ehlena
|
RU2393866C2 |
ANALGETIC AGENT ON THE BASIS OF PLASMID DNA CODING HNP-1, OR HNP-2, OR HNP-3 (VERSIONS) |
2014 |
- Dukhovlinov Ilya Vladimirovich
- Orlov Anton Iosifovich
|
RU2597789C2 |
APPLICATION OF 4-AMINOPYRIDINE FOR IMPROVING CONDITION IN CASE OF NEUROCOGNITIVE AND/OR NEUROPSYCHIATRIC DISORDER IN PATIENTS WITH DEMYELINATING AND OTHER DISEASES OF NERVOUS SYSTEM |
2010 |
- Vessel' Tomas K.
- Blajt Ehndrju
|
RU2563821C2 |
PHARMACEUTICAL COMPOSITION FOR GENETIC THERAPY OF DISEASES REQUIRING STIMULATION OF REGENERATIVE PROCESSES, INCLUDING HUMAN TISSUE DAMAGES OF VARIOUS AETIOLOGIES, BASED ON SYNTHETIC MODIFIED GENE OF INSULIN-LIKE HUMAN GROWTH FACTOR TYPE ONE (IFR-1, IGF-1) |
2007 |
- Ivanov Igor' Al'Bertovich
|
RU2372941C2 |
SOBETIROME DERIVATIVES |
2017 |
- Scanlan, Thomas
- Devereaux, Jordan
- Placzek, Andrew
- Banerji, Tapasree
- Ferrara, Skylar
- Meinig, James Matthew
- Banerji, Tania
|
RU2776372C2 |